Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Choice of surrogate and physiological markers for prenatal gene therapy.

Delhove JM, Rahim AA, McKay TR, Waddington SN, Buckley SM.

Methods Mol Biol. 2012;891:273-90. doi: 10.1007/978-1-61779-873-3_13.

PMID:
22648777
2.

Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.

Schneider H, Adebakin S, Themis M, Cook T, Douar AM, Pavirani A, Coutelle C.

J Gene Med. 1999 Nov-Dec;1(6):424-32.

PMID:
10753068
3.
4.

Vector systems for prenatal gene therapy: principles of retrovirus vector design and production.

Howe SJ, Chandrashekran A.

Methods Mol Biol. 2012;891:85-107. doi: 10.1007/978-1-61779-873-3_5.

PMID:
22648769
5.

Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein.

Themis M, Schneider H, Kiserud T, Cook T, Adebakin S, Jezzard S, Forbes S, Hanson M, Pavirani A, Rodeck C, Coutelle C.

Gene Ther. 1999 Jul;6(7):1239-48.

6.

Vector systems for prenatal gene therapy: choosing vectors for different applications.

Coutelle C, Waddington SN.

Methods Mol Biol. 2012;891:41-53. doi: 10.1007/978-1-61779-873-3_3. Review.

PMID:
22648767
7.

No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.

Jakob M, Mühle C, Park J, Weiss S, Waddington S, Schneider H.

J Gene Med. 2005 May;7(5):630-7.

PMID:
15693035
8.

Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle.

Grønevik E, von Steyern FV, Kalhovde JM, Tjelle TE, Mathiesen I.

J Gene Med. 2005 Feb;7(2):218-27.

PMID:
15515140
9.

Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.

Shao G, Greathouse K, Huang Q, Wang CM, Sferra TJ.

J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):168-79.

PMID:
16877980
10.

Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering.

Chuang CK, Sung LY, Hwang SM, Lo WH, Chen HC, Hu YC.

Gene Ther. 2007 Oct;14(19):1417-24. Epub 2007 Jul 19.

PMID:
17637796
11.

Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.

Kikuchi J, Mimuro J, Ogata K, Tabata T, Ueda Y, Ishiwata A, Kimura K, Takano K, Madoiwa S, Mizukami H, Hanazono Y, Kume A, Hasegawa M, Ozawa K, Sakata Y.

J Gene Med. 2004 Oct;6(10):1049-60. Erratum in: J Gene Med. 2005 Jun;7(6):836. Kimura, Konzoh [corrected to Kimura, Kouzoh].

PMID:
15386735
12.

AAV-mediated gene transfer for hemophilia.

High KA.

Ann N Y Acad Sci. 2001 Dec;953:64-74. Review.

PMID:
11795424
13.

Gene transfer as an approach to treating hemophilia.

High KA.

Circ Res. 2001 Feb 2;88(2):137-44. Review.

14.

Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes.

Bitzer M, Ungerechts G, Bossow S, Graepler F, Sedlmeier R, Armeanu S, Bernloehr C, Spiegel M, Gross CD, Gregor M, Neubert WJ, Lauer UM.

Mol Ther. 2003 Feb;7(2):210-7.

PMID:
12597909
15.

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.

Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA.

Nat Genet. 1997 Jul;16(3):270-6.

PMID:
9207793
16.
17.

Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.

Schneider H, Mühle C, Douar AM, Waddington S, Jiang QJ, von der Mark K, Coutelle C, Rascher W.

J Gene Med. 2002 Jan-Feb;4(1):46-53.

PMID:
11828387
18.

Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.

Kunke D, Grimm D, Denger S, Kreuzer J, Delius H, Komitowski D, Kleinschmidt JA.

Cancer Gene Ther. 2000 May;7(5):766-77.

19.

Gene marking of human neural stem/precursor cells using green fluorescent proteins.

Navarro-Galve B, Villa A, Bueno C, Thompson L, Johansen J, Martínez-Serrano A.

J Gene Med. 2005 Jan;7(1):18-29.

PMID:
15508144
20.

Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.

Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, Curiel DT.

Clin Cancer Res. 2003 Jul;9(7):2701-10.

Items per page

Supplemental Content

Write to the Help Desk